Successful treatment of pulmonary mucormycosis in two pediatric hematopoietic stem cell transplant patients

Pediatric Transplantation
Caitlin W ElgartenJason L Freedman

Abstract

Pulmonary mucormycosis diagnosed immediately after hematopoietic stem cell transplantation frequently portends a poor prognosis. However, here we describe two cases in children that were treated successfully to highlight the efficacy of a multidisciplinary approach. Despite diagnosis in the immediate post-transplant period and requirement for ongoing immunosuppression to prevent or treat GVHD, both are long-term survivors due to early surgical debridement with transfusion support and prompt initiation of targeted antifungal therapy. In the absence of evidence-based treatment guidelines, survival of pulmonary mucormycosis is achievable even in high-risk patients with a multidisciplinary team to guide management.

References

Jul 1, 1999·Archives of Internal Medicine·F Y LeeK A Adal
Apr 17, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J W BaddleyP G Pappas
Sep 14, 2004·Leukemia & Lymphoma·B GleissnerE Thiel
Mar 3, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jo-Anne H van BurikDimitrios P Kontoyiannis
Sep 11, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carol Garcia-VidalKieren A Marr
Jan 5, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A SkiadaUNKNOWN European Confederation of Medical Mycology Working Group on Zygomycosis
May 31, 2011·Blood·Dimitrios P Kontoyiannis, Russell E Lewis
Dec 15, 2011·Seminars in Respiratory and Critical Care Medicine·Georgios HamilosDimitrios P Kontoyiannis
Feb 2, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F LanternierUNKNOWN French Mycosis Study Group
Jan 4, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M Cuenca-EstrellaUNKNOWN ESCMID Fungal Infection Study Group
Oct 24, 2013·Mycoses·Dimitrios P KontoyiannisDavid L Horn
Jun 25, 2014·Emerging Infectious Diseases·Dounia BitarFrançoise Dromer
Nov 20, 2015·Journal of the Pediatric Infectious Diseases Society·Rachel L WattierWilliam J Steinbach
Apr 18, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A KyvernitakisD P Kontoyiannis
May 19, 2016·Current Opinion in Infectious Diseases·Maria N Chitasombat, Dimitrios P Kontoyiannis
Feb 22, 2017·Infection·Erica LinAndrew H Limper

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.